BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 11884591)

  • 1. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.
    Kops GJ; Medema RH; Glassford J; Essers MA; Dijkers PF; Coffer PJ; Lam EW; Burgering BM
    Mol Cell Biol; 2002 Apr; 22(7):2025-36. PubMed ID: 11884591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.
    Schmidt M; Fernandez de Mattos S; van der Horst A; Klompmaker R; Kops GJ; Lam EW; Burgering BM; Medema RH
    Mol Cell Biol; 2002 Nov; 22(22):7842-52. PubMed ID: 12391153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.
    Medema RH; Kops GJ; Bos JL; Burgering BM
    Nature; 2000 Apr; 404(6779):782-7. PubMed ID: 10783894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
    Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
    J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).
    Dijkers PF; Medema RH; Pals C; Banerji L; Thomas NS; Lam EW; Burgering BM; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Mol Cell Biol; 2000 Dec; 20(24):9138-48. PubMed ID: 11094066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.
    Stahl M; Dijkers PF; Kops GJ; Lens SM; Coffer PJ; Burgering BM; Medema RH
    J Immunol; 2002 May; 168(10):5024-31. PubMed ID: 11994454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells.
    Sedding DG; Seay U; Fink L; Heil M; Kummer W; Tillmanns H; Braun-Dullaeus RC
    Circulation; 2003 Aug; 108(5):616-22. PubMed ID: 12835226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression.
    Zhang L; Wang C
    J Biol Chem; 2003 Jan; 278(1):27-36. PubMed ID: 12401804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle and death control: long live Forkheads.
    Burgering BM; Kops GJ
    Trends Biochem Sci; 2002 Jul; 27(7):352-60. PubMed ID: 12114024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
    Liang J; Slingerland JM
    Cell Cycle; 2003; 2(4):339-45. PubMed ID: 12851486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation.
    Ewton DZ; Kansra S; Lim S; Friedman E
    Int J Cancer; 2002 Apr; 98(5):665-73. PubMed ID: 11920634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.
    Brennan P; Babbage JW; Burgering BM; Groner B; Reif K; Cantrell DA
    Immunity; 1997 Nov; 7(5):679-89. PubMed ID: 9390691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
    Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins.
    Richards JS; Sharma SC; Falender AE; Lo YH
    Mol Endocrinol; 2002 Mar; 16(3):580-99. PubMed ID: 11875118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.